Tome Biosciences

Developer of gene insertion platform for genomic medicines

placeCambridge, Massachusetts, United States calendar_todayFounded 2021 groups123 employees language tome.bio

Investor mix

8 investors on record; lead investors include Andreessen Horowitz, Arch Venture Partners, Google Ventures, Longwood Fund.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%
Coming soon